Copyright Reports & Markets. All rights reserved.

Global Gefitinib API Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Gefitinib API Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Purity ≥ 98 %
      • 1.2.2 Purity ≥ 99 %
    • 1.3 Market Analysis by Applications
      • 1.3.1 Gefitinib Tablets
      • 1.3.2 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Scion Pharm Taiwan
      • 2.1.1 Business Overview
      • 2.1.2 Gefitinib API Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Scion Pharm Taiwan Gefitinib API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Nischem International
      • 2.2.1 Business Overview
      • 2.2.2 Gefitinib API Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Nischem International Gefitinib API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Jeil Pharmaceutical
      • 2.3.1 Business Overview
      • 2.3.2 Gefitinib API Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Jeil Pharmaceutical Gefitinib API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Farmhispania Group
      • 2.4.1 Business Overview
      • 2.4.2 Gefitinib API Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Farmhispania Group Gefitinib API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Brawn Laboratories
      • 2.5.1 Business Overview
      • 2.5.2 Gefitinib API Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Brawn Laboratories Gefitinib API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Chem Genix
      • 2.6.1 Business Overview
      • 2.6.2 Gefitinib API Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Chem Genix Gefitinib API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Qilu Pharmaceutial
      • 2.7.1 Business Overview
      • 2.7.2 Gefitinib API Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Qilu Pharmaceutial Gefitinib API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Cipla
      • 2.8.1 Business Overview
      • 2.8.2 Gefitinib API Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Cipla Gefitinib API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Zhuhai Rundu Pharma
      • 2.9.1 Business Overview
      • 2.9.2 Gefitinib API Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Zhuhai Rundu Pharma Gefitinib API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Zhejiang Hisun Pharmaceutical
      • 2.10.1 Business Overview
      • 2.10.2 Gefitinib API Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Zhejiang Hisun Pharmaceutical Gefitinib API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Gefitinib API Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Gefitinib API Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Gefitinib API Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Gefitinib API Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Gefitinib API Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Gefitinib API Market Analysis by Regions

    • 4.1 Global Gefitinib API Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Gefitinib API Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Gefitinib API Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Gefitinib API Sales and Growth Rate (2014-2019)
    • 4.3 Europe Gefitinib API Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Gefitinib API Sales and Growth Rate (2014-2019)
    • 4.5 South America Gefitinib API Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Gefitinib API Sales and Growth Rate (2014-2019)

    5 North America Gefitinib API by Country

    • 5.1 North America Gefitinib API Sales, Revenue and Market Share by Country
      • 5.1.1 North America Gefitinib API Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Gefitinib API Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Gefitinib API Sales and Growth Rate (2014-2019)
    • 5.3 Canada Gefitinib API Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Gefitinib API Sales and Growth Rate (2014-2019)

    6 Europe Gefitinib API by Country

    • 6.1 Europe Gefitinib API Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Gefitinib API Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Gefitinib API Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Gefitinib API Sales and Growth Rate (2014-2019)
    • 6.3 UK Gefitinib API Sales and Growth Rate (2014-2019)
    • 6.4 France Gefitinib API Sales and Growth Rate (2014-2019)
    • 6.5 Russia Gefitinib API Sales and Growth Rate (2014-2019)
    • 6.6 Italy Gefitinib API Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Gefitinib API by Country

    • 7.1 Asia-Pacific Gefitinib API Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Gefitinib API Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Gefitinib API Revenue and Market Share by Country (2014-2019)
    • 7.2 China Gefitinib API Sales and Growth Rate (2014-2019)
    • 7.3 Japan Gefitinib API Sales and Growth Rate (2014-2019)
    • 7.4 Korea Gefitinib API Sales and Growth Rate (2014-2019)
    • 7.5 India Gefitinib API Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Gefitinib API Sales and Growth Rate (2014-2019)

    8 South America Gefitinib API by Country

    • 8.1 South America Gefitinib API Sales, Revenue and Market Share by Country
      • 8.1.1 South America Gefitinib API Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Gefitinib API Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Gefitinib API Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Gefitinib API Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Gefitinib API Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Gefitinib API by Countries

    • 9.1 Middle East and Africa Gefitinib API Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Gefitinib API Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Gefitinib API Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Gefitinib API Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Gefitinib API Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Gefitinib API Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Gefitinib API Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Gefitinib API Sales and Growth Rate (2014-2019)

    10 Global Gefitinib API Market Segment by Type

    • 10.1 Global Gefitinib API Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Gefitinib API Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Gefitinib API Revenue and Market Share by Type (2014-2019)
    • 10.2 Purity ≥ 98 % Sales Growth and Price
      • 10.2.1 Global Purity ≥ 98 % Sales Growth (2014-2019)
      • 10.2.2 Global Purity ≥ 98 % Price (2014-2019)
    • 10.3 Purity ≥ 99 % Sales Growth and Price
      • 10.3.1 Global Purity ≥ 99 % Sales Growth (2014-2019)
      • 10.3.2 Global Purity ≥ 99 % Price (2014-2019)

    11 Global Gefitinib API Market Segment by Application

    • 11.1 Global Gefitinib API Sales Market Share by Application (2014-2019)
    • 11.2 Gefitinib Tablets Sales Growth (2014-2019)
    • 11.3 Other Sales Growth (2014-2019)

    12 Gefitinib API Market Forecast (2019-2024)

    • 12.1 Global Gefitinib API Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Gefitinib API Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Gefitinib API Market Forecast (2019-2024)
      • 12.2.2 Europe Gefitinib API Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Gefitinib API Market Forecast (2019-2024)
      • 12.2.4 South America Gefitinib API Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Gefitinib API Market Forecast (2019-2024)
    • 12.3 Gefitinib API Market Forecast by Type (2019-2024)
      • 12.3.1 Global Gefitinib API Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Gefitinib API Market Share Forecast by Type (2019-2024)
    • 12.4 Gefitinib API Market Forecast by Application (2019-2024)
      • 12.4.1 Global Gefitinib API Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Gefitinib API Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Description

      Scope of the Report:
      The worldwide market for Gefitinib API is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Gefitinib API in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Scion Pharm Taiwan
      Nischem International
      Jeil Pharmaceutical
      Farmhispania Group
      Brawn Laboratories
      Chem Genix
      Qilu Pharmaceutial
      Cipla
      Zhuhai Rundu Pharma
      Zhejiang Hisun Pharmaceutical

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Purity ≥ 98 %
      Purity ≥ 99 %

      Market Segment by Applications, can be divided into
      Gefitinib Tablets
      Other

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Gefitinib API product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Gefitinib API, with price, sales, revenue and global market share of Gefitinib API in 2017 and 2018.
      Chapter 3, the Gefitinib API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Gefitinib API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Gefitinib API market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Gefitinib API sales channel, distributors, customers, research findings and conclusion, appendix and data source.
      Buy now